Branched-chain amino acids accumulating in maple syrup urine disease induce morphological alterations in C6 glioma cells probably through reactive species

International Journal of Developmental Neuroscience

Volumn 25, Issue 3, 2007, Pages 181-189

  de Lima Pelaez, Priscila ^a   Funchal, Cláudia ^a   Loureiro, Samanta Oliveira ^a   Heimfarth, Luana ^a   Zamoner, Ariane ^a   Gottfried, Carmem ^a   Latini, Alexandra ^a   Wajner, Moacir ^a   Pessoa Pureur, Regina ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Branched chain amino acids; Cell morphology; Cytoskeleton

Indexed keywords

ACTIN; BRANCHED CHAIN AMINO ACID; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE; INTERMEDIATE FILAMENT PROTEIN; ISOLEUCINE; LEUCINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; VALINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELL CULTURE; CELL DEATH; CELL MATURATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOSKELETON; GLIOMA CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; INTERMEDIATE FILAMENT; MAPLE SYRUP URINE DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ACTINS; AGE FACTORS; AMINO ACIDS, BRANCHED-CHAIN; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; CELL LINE, TUMOR; CEREBELLUM; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOMA; GLUTATHIONE; NITRIC OXIDE; RATS; RATS, WISTAR; TIME FACTORS;

ACER; RATTUS;

EID: 34247390739     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2007.01.001     Document Type: Article

References (48)

1. Bellomo G., Mirabelli F., Vairerri M., Iosi F., and Malomi W. Cas a target in menadione-induced oxidative stress in cultured mammalian cells. Biochemical and immunocytochemical features. J. Cell Physiol. 143 (1990) 118-128
2. Benda P., Lightbody J., Sato G., Levine L., and Sweet W. Differentiated rat glial cell strain in culture. Science 161 (1968) 370-371
3. Bridi R., Araldi J., Sgarbi M.B., Testa C.G., Durigon K., Wajner M., and Dutra-Filho C.S. Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease. Int. J. Dev. Neurosci. 21 (2003) 327-332
4. Bridi R., Braun C.A., Zorzi G.K., Wannmacher C.M., Wajner M., Lissi E.G., and Dutra-Filho C.S. Alpha-keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defences in cerebral cortex from young rats. Met. Brain Dis. 20 (2005) 155-167
5. Bridi R., Latini A., Braun C.A., Zorzi G.K., Wajner M., Lissi E.G., and Dutra-Filho C.S. Evaluation of the mechanisms involved in leucine-induced oxidative damage in cerebral córtex of young rats. Free Radic. Res. 39 (2005) 71-79
6. Browne R.W., and Armstrong D. Reduced glutathione disulfide. Methods Mol. Biol. 108 (1998) 347-352
7. Chuang D.T., and Shih V.E. Maple syrup urine disease (branched-chain ketoaciduria). The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw-Hill, New York pp. 1971-2005
8. Cimarosti H., Rodnight R., Tavares A., Paiva R., Valentim L., Rocha E., and Salbego C. An investigation of the neuroprotective effect of lithium in organotypic slice cultures of rat hyppocampus exposed to oxygen and glucose deprivation. Neurosci. Lett. 315 (2001) 33-36
9. Danner D.J., and Elsas J.L. Disorders of branched chain amino acid and keto acid metabolism. The Metabolic Basis of Inherited Disease (1989), McGraw-Hill, New York pp. 671-692
10. Davis R.L., Sanchez A.C., Lindney D.J., Williams S.C., and Syapin P.J. Effects of mechanistically distinct NF-kappaB inhibitors on glial inducible nitric-oxide synthase expression. Nitric Oxide 12 (2005) 200-209
11. Dent E.W., and Gestler F.B. Cytoskeletal dynamics and transport in growth cone motility and axon guidance. Neuron 40 (2003) 209-227
12. Dringen R., Gutterer J.M., and Hirrlinger J. Glutathione metabolism in brain: metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur. J. Biochem. 267 (2000) 4912-4916
13. Efron M.L. Aminoaciduria. N. Engl. J. Med. 272 (1965) 1058-1067
14. Fontella F.U., Gassen E., Pulrolni V., Wannmacher C.M.D., Klein A.B., Wajner M., and Dutra-Filho C.S. Stimulation of lipid peroxidation in vitro in rat brain by the metabolites accumulating in maple syrup urine disease. Metab. Brain Dis. 17 (2002) 47-54
15. Funchal C., de Lima Pelaez P., Oliveira Loureiro S., Vivian L., Dall Bell Pessutto F., Vieira de Almeida L.M., Tchernin Wofchuk S., Wajner M., and Pessoa-Pureur R. α-Ketoisocaproic acid regulates phosphorylation of intermediate filaments in postnatal rat cortical slices through ionotropic glutamatergic receptors. Dev. Brain Res. 139 (2002) 267-276
16. Funchal C., Vieira de Almeida L.M., Oliveira Loureiro S., Vilian L., de Lima Pelaez P., Dall Bello Pessutto F., Meyer Rosa A., Wajner M., and Pessoa-Pureur R. In vitro phosphorylation of cytoskeletal proteins from cerebral cortex of rats. Brain Res. Prot. 11 (2003) 111-118
17. Funchal C., Rosa A.M., Wajner M., Wofchuk S., and Pessoa-Pureur R. Reduction of glutamate uptake into cerebral cortex of developing rats by the branched-chain α-keto acids accumulating in maple syrup urine disease. Neurochem. Res. 29 (2004) 747-753
18. Funchal C., Gottfried C., Vieira de Almeida L.M., Wajner M., and Pessoa-Pureur R. Evidence that the branched-chain α-keto acids accumulating in maple syrup urine disease induce morphological alterations and death in cultured astrocytes from rat cerebral córtex. Glia 48 (2004) 230-241
19. Funchal C., Gottfried C., Vieira de Almeida L.M., Quincozes dos Santos A., Wajner M., and Pessoa-Pureur R. Morphological alterations and cell death provoked by the branched-chain α-amino acids accumulating in maple syrup urine disease in astrocytes from rat cerebral cortex. Cell Mol. Neurobiol. 25 (2005) 851-867
20. Funchal C., Quincozes dos Santos A., Jacques-Silva M.C., Zamoner A., Gottfried C., Wajner M., and Pessoa-Pureur R. Branched-chain α-keto acids accumulating in maple syrup urine disease induce reorganization of phosphorylated GFAP in C6-glioma cells. Metab. Brain Dis. 20 (2005) 205-217
21. Funchal C., Latini A., Jacques-Silva M.C., Quincozes dos Santos A., Buzin L., Gottfried C., Wajner M., and Pessoa-Pureur R. Morphological alterations and induction of oxidative stress in glial cells caused by the branched-chain α-keto acids accumulating in maple syrup urine disease. Neurochem. Int. 49 (2006) 640-650
22. Gourlay C.W., and Ayscough K.R. The actin cytoskeleton: a key regulator of apoptosis and ageing?. Nat. Rev. 6 (2005) 583-589
23. Grant P., and Pant H.C. Neurofilament protein synthesis and phosphorylation. J. Neurocytol. 29 (2000) 843-872
24. Haghighat N., and McCandless D.W. Effect of ammonium chloride on energy metabolism of astrocytes and C6-glioma cells. Met. Brain Dis. 12 (1997) 287-298
25. Haghighat N., McCandless D.W., and Geraminegad P. Responses in primary astrocytes and C6-glioma cells to ammonium chloride and dibutyryl cyclic-AMP. Neurochem. Res. 25 (2000) 277-284
26. Halestrap A., Brand M.D., and Denton R.M. Inhibition of mitochondrial pyruvate transport by phenylpyruvate and α-ketoisocaproate. Biochem. Biophys. Acta 367 (1974) 102-108
27. Halliwell B., and Gutteridge J.M.C. Oxygen radicals and nervous system. Trends Neurosci. 8 (1996) 22-26
28. Hevel J.M., and Marlett M.A. Nitric oxide synthase assays. Methods Enzymol. 233 (1994) 250-258
29. Hinshaw D.B., Burger J.M., Beails T.F., Armstrong B.C., and Hyslop P.A. Actin polymerization in cellular oxidant injury. Arch. Biochem. Biophys. 288 (1991) 311-316
30. Howell R.K., and Lee M. Influence of alpha-ketoacids on the respiration of brain in vitro. Proc. Soc. Exp. Biol. Med. 113 (1963) 660-663
31. Inagaki M., Nakamura Y., Takeda M., Nishimura T., and Inagaki M. Glial fibrillary acidic protein: dynamic property and regulation by phosphorylation. Brain Pathol. 4 (1994) 239-243
32. Jouvet P., Rustin P., Taylor D.L., Pocock J.M., Felderhoff-Mueser U., Mazarakis N.D., Sarrat C., Joashi U., Kozma M., Greewood K., Edwards A.D., and Mehmet H. Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease. Mol. Biol. Cell 11 (2000) 1919-1932
33. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 277 (1970) 680-685
34. Land J.M., Mowbray J., and Clark J.B. Control of pyruvate and β-hydroxy-butyrate utilization in rat brain mitochondria and its relevance to phenylketonuria and maple syrup urine disease. J. Neurochem. 26 (1976) 823-830
35. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-267
36. Nord A., Van Doorninck W.J., and Greene C. Developmental profile of patients with maple syrup urine disease. J. Inherit. Metab. Dis. 14 (1991) 881-889
37. Parker K.P., Norenberg M.D., and Vernadakis A. "Transdifferentiation" of C6 glial cells in culture. Science 208 (1980) 179-181
38. Pilla C., Cardozo R.F., Dutra-Filho C.S., Wyse A.T., Wajner M., and Wannmacher C.M. Creatine kinase activity from rat brain is inhibited by branched-chain amino acids in vitro. Neurochem. Res. 28 (2003) 675-679
39. Rodrigez-Martin E., Casajeros M.J., Canals S., de Bernardo S., and Mena M.A. Thiolic antioxidants protect from nitric oxide-induced toxicity in fetal midbrain cultures. Neuropharmacology 43 (2002) 877-888
40. Sagara J.I., Miura K., and Bannai S. Maintenance of neuronal glutathione by glial cells. J. Neurochem. 61 (1993) 1672-1676
41. Sgaravati A.M., Rosa R.B., Schuck P.F., Ribeiro C.A.J., Wannmacher C.M.D., Wyse A.T.S., Dutra-Filho C.S., and Wajner M. Inhibition of brain energy metabolism by the α-keto acids accumulating in maple syrup urine disease. Biochim. Biophys. Acta 1639 (2003) 232-238
42. Sies H. Oxidative stress: introductory remarks. Oxidative Stress (1985), Academic Press, London pp. 1-8
43. Stamler J.S., and Toone E.J. The decomposition of thionitrites. Curr. Opin. Chem. Biol. 6 (2002) 779-785
44. Stone R., Stewart V.C., Hurst R.D., Clark J.B., and Heales S.J. Astrocyte nitric oxide causes neuronal mitochondrial damage, but antioxidant release limits neuronal cell death. Ann. N.Y. Acad. Sci. 893 (1999) 400-403
45. Tashian R.E. Inhibition of brain glutamic acid decarboxilase by phenylalanine, valine, and leucine derivatives: a suggestion concerning the etiology of the neurological defect in phenylketonuria and branched-chain ketonuria. Metabolism 10 (1961) 393-402
46. Tavares R.G., Santos C.E.F., Tasca C., Wajner M., Souza D.O., and Dutra-Filho C.S. Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease. J. Neurol. Sci. 181 (2000) 44-49
47. Toda M., Miura M., Asou H., Toya S., and Uyemura K. Cell growth suppression of astrocytoma C6 cells by GFAP cDNA transfection. J. Neurochem. 63 (1994) 1975-1978
48. Won J.S., Im Y.B., Singh A.K., and Singh I. Dual role of cAMP in iNOS expression in glial cells and macrophages is mediated by differential regulation of p38-MAPK/ATF-2 activation and iNOS stability. Free Radic. Biol. Med. 37 (2004) 1834-1844